FDA Investigator Colleen M Damon
Colleen M Damon has conducted inspections on 8 sites in 1 countries as of 07 Dec 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
07 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Colleen M Damon:
Amanda B Athey,
Amanda B Vega,
Anastasia M Shields,
Anita R Michael,
Ann Marie Karnick,
Anthony A Charity,
Audrey Thereset Uy,
Brian S Keefer,
Cara M Minelli,
Carl E Lovrich,
Charles M Edwards,
Craig D Zagata,
Daniel P Becker,
David A Oluwo,
David J Hafner,
Dawn D Aiello,
Debra J Bennett,
Debra L Pagano,
Denise M Digiulio,
Edward D Mcdonald,
Gayle S Lawson,
Jaison J Eapen,
James C Illuminati,
James M Mason,
James P Mcevoy,
Jean Blackston Hill,
Jeen S Min,
Joanne Heim,
Joanne M Hajoway,
Julianne C Mccullough,
Karyn M Campbell,
Kendra L Brooks,
Kenneth M Gordon,
Kimberly A Dux,
Kristen D Evans,
Kristina J Donohue,
Kristina Mjoyce Pittman,
LCDR Margaret Edi Gennaro,
Lisa B Orr,
Lisa M Bellows,
LT John M Mastalski,
LTJG Bradley E Benasutti,
Luella J Rossi,
Luis A Dasta,
Marea K Harmon,
Maria A Reed,
Matthew R Noonan,
Maureen A Wentzel,
Michael Gurbarg,
Michael J Nerz,
Michael L Casner,
Michele Gottshall,
Michele M Falchek,
Raffi B Papazian,
Richard J Bashay,
Robert B Shibuya, MD,
Robert J Maffei,
Sam Pepe,
Sharon K Thoma, PharmD,
Stephanie Mangigian, MS/OSH, RN,
Stephen J Koniers,
Susan F Laska, MS,
Temar Q Williams,
Thomas E Friel,
Vlada Matusovsky
Colleen M Damon's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2000 | EIR | Accupac, LLC - EIR, 2000-04-13 |
March, 2000 | FDA 483 | Fisher Clinical Services Inc. - Form 483, 2000-03-09 |
April, 2000 | FDA 483 | Accupac, LLC - Form 483, 2000-04-13 |
March, 2000 | EIR | Fisher Clinical Services Inc. - EIR, 2000-03-09 |
April, 2000 | FDA 483 Response | Accupac, LLC - Form 483R, 2000-05-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more